ATARA BIOTHERAPEUTICS, INC. Restructuring Reserve
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Restructuring Reserve of $767.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2026-08-12
- 2026-06-30: Restructuring Reserve $767.00K.
- 2026-03-31: Restructuring Reserve $125.00K.
- 2025-12-31: Restructuring Reserve $871.00K.
- 2025-09-30: Restructuring Reserve $1.21M.
| Period end | Restructuring Reserve |
|---|---|
| 2026-06-30 | $767.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $125.00K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $871.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $1.21M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $2.84M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $6.92M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $63.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $207.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $884.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $2.42M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $4.92M 10-K · filed 2026-03-16 |
| 2023-09-30 | $77.00K 10-Q · filed 2023-11-01 |
| 2023-06-30 | $506.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $738.00K 10-Q · filed 2023-05-08 |
| 2022-12-31 | $1.54M 10-K · filed 2025-03-07 |
| 2022-09-30 | $4.08M 10-Q · filed 2022-11-08 |
| 2021-12-31 | $0.00 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |